PredictImmune Overview

  • Year Founded
  • 2017

Year Founded

  • Status
  • Out of Business

  • Employees
  • 13

Employees

  • Latest Deal Type
  • Liquidation

PredictImmune General Information

Description

Developer of prognostic tools designed to guide treatment options in immune-mediated inflammatory diseases. The company's products offer personalized treatment options for inflammatory bowel disease through the prediction of long-term clinical prognosis by providing additional information to support treatment choices, enabling doctors to identify patients who are at risk of experiencing severe relapsing disease.

Contact Information

Website
www.predictimmune.com
Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • 3 Field Court, Gray's Inn
  • London WC1R 5EF
  • England, United Kingdom
Primary Industry
Outcome Management (Healthcare)
Vertical(s)
Digital Health, HealthTech, Life Sciences
Corporate Office
  • 3 Field Court, Gray's Inn
  • London WC1R 5EF
  • England, United Kingdom

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

PredictImmune Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Bankruptcy: Liquidation 25-Feb-2024 Completed Bankruptcy: Liquidation
6. Early Stage VC (Series 1) 12-May-2021 Completed Generating Revenue
5. Early Stage VC (Series B) 13-Jul-2019 Completed Generating Revenue
4. Grant 13-Dec-2018 Completed Generating Revenue
3. Grant 30-Apr-2018 Completed Generating Revenue
2. Early Stage VC (Series A) 10-May-2017 $6.04M $6.04M Completed Generating Revenue
1. University Spin-Out 01-Jan-2017 Completed Startup
To view PredictImmune’s complete valuation and funding history, request access »

PredictImmune Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
A Ordinary
Ordinary
To view PredictImmune’s complete cap table history, request access »

PredictImmune Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Ready to get started?

Request a free trial

PredictImmune FAQs

  • When was PredictImmune founded?

    PredictImmune was founded in 2017.

  • Where is PredictImmune headquartered?

    PredictImmune is headquartered in London, United Kingdom.

  • What is the size of PredictImmune?

    PredictImmune has 13 total employees.

  • What industry is PredictImmune in?

    PredictImmune’s primary industry is Outcome Management (Healthcare).

  • Is PredictImmune a private or public company?

    PredictImmune is a Private company.

  • What is PredictImmune’s current revenue?

    The current revenue for PredictImmune is .

  • How much funding has PredictImmune raised over time?

    PredictImmune has raised $20.7M.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process